hims & hers glp 1 A New Era of Weight Management is Coming to Hims to begin selling GLP-1
Description
Both are made by the Danish company Novo Nordisk
Both platforms require a medical evaluation to determine eligibility for GLP-1 medications
Welldocs digital health platform understands this synergy
doi: 10.1517/14656566.7.15.2095 143 PedrosaMRFrancoDRGieremekHWVidalCMBronzeriFde Cassia RochaAet al
Retatrutide is a triple agonist it targets GLP-1, GIP, and glucagon receptors simultaneously
PD clinical trials The neuroprotective effects of GLP-1RAs, particularly exenatide, seem to be more promising in PD
